KFDA to toughen administrative regulations on substandard drugs

Published: 2003-06-13 07:00:00

Updated: 2003-06-13 07:00:00

The Korea Food and Drug Administration said recently that intensive administrative efforts will be made to curb the manufacture and distribution of counterfeit or substandard drugs through the introduction of a new ranking-based certification system on the level of each pharmaceutical firm and to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK